What is a steroid emergency card and do I need one?
The NHS Steroid Emergency Card was introduced in 2020 to help emergency staff spot people whose bodies may rely on steroid medicine and who are at risk of adrenal crisis if they are very unwell. The NHS says that, depending on your condition and how long you take prednisolone, you may be given a blue steroid card and a red steroid emergency card. Crohn's & Colitis UK advises carrying your card at all times. Ask your IBD team or pharmacist whether you need one.
Can I stop taking steroids suddenly if I feel better?
No. Crohn's & Colitis UK says you should never stop steroids suddenly, even if you feel well. After a while on steroid tablets your body may make less of its own natural steroid, so stopping abruptly can lead to adrenal insufficiency, which can be serious. Steroids are usually reduced gradually (tapered) on a plan from your IBD team. Talk to them before making any change.
Budesonide (brands include Entocort and Budenofalk) is a steroid that acts mainly in the gut and is largely broken down by the liver. A Cochrane review found it is a little less effective than standard steroids such as prednisolone, but has fewer side effects. NICE suggests it may be considered for a first flare in the end of the small bowel or right side of the colon, but not for severe flares, and a Cochrane review found it does not keep Crohn's in remission.
Am I entitled to the free flu jab and COVID booster?
Crohn's & Colitis UK says having Crohn's does not on its own make you eligible for the NHS flu, COVID-19 booster or RSV vaccines, but taking medicines that weaken the immune system may. Examples include azathioprine, mercaptopurine, methotrexate, biologics, newer targeted tablets and higher doses of steroids. The NHS flu page lists people with a weakened immune system among those offered the vaccine. Ask your GP or IBD team if you are unsure.
Steroids such as prednisolone work well for calming a flare, but they cause side effects that become more likely the longer you take them. Crohn's & Colitis UK lists effects such as mood changes, sleep problems, skin changes and stomach problems. Cochrane reviews show steroids help bring Crohn's into remission, but budesonide does not keep it in remission long term. The 2025 BSG guideline warns against long or repeated steroid courses.
The NHS medicine guide to prednisolone, a steroid that calms inflammation and is used in conditions including Crohn's disease. It covers how to take it, side effects, and why you may be given a blue steroid card and a red steroid emergency card depending on how long you take it.
The charity's guide to steroids for Crohn's and Colitis, covering prednisolone, budesonide (brands such as Budenofalk and Entocort) and other forms. It explains side effects, why steroids are only for short-term use, why you must never stop suddenly, how the dose is gradually reduced, the risk of adrenal insufficiency, and carrying a steroid card.
The 2020 national safety alert that introduced the NHS Steroid Emergency Card for adults whose bodies may depend on steroid medicine. The card helps hospital staff spot people at risk of adrenal crisis and treat them quickly in an emergency.
CochraneSystematic reviewJun 2015Patients and professionals
Budesonide, a steroid that acts mainly in the gut, works better than placebo for bringing on remission. It is a bit less effective than standard steroids such as prednisolone, especially for severe or widespread colon disease, but causes fewer side effects and less suppression of the body's own steroid production.
A summary of the 2026 flu, COVID-19 booster and RSV vaccines across the four UK nations. Having Crohn's alone does not make you eligible, but taking immune-lowering medicines such as azathioprine, methotrexate, biologics, targeted tablets or higher-dose steroids may. Speak to your healthcare team if you are unsure.
European Crohn's and Colitis Organisation (J Crohns Colitis)GuidelineOct 2024For professionals
Europe's main expert guideline on which medicines to use for Crohn's disease, published as the first of a two-part set (the second covers surgery). It weighs up the trial evidence for steroids, immunosuppressants, biologics and newer tablets, including treatment of disease around the back passage. UK specialists use it alongside the BSG guideline.